LOADING....!!!!!
Pharmica.co.uk: Medication and Disease Information Portal

GDPR Compliance

published : Apr, 26 2023

General Data Protection Regulation (GDPR) Compliance

At Pharmica.co.uk, we recognize the importance of privacy and are fully committed to being compliant with the General Data Protection Regulation (GDPR). We are dedicated to maintaining the security, confidentiality, and integrity of the personal information we collect from our visitors and customers. This page outlines our practices regarding data collection, processing, and storage in accordance with GDPR requirements.

Data Collection and Use

We collect personal data only when it is necessary for the services we provide. This includes personal health information, contact details, and transactional data. We ensure that the information is processed in a lawful, fair, and transparent manner, and is used for specified, explicit, and legitimate purposes only.

Data Subject Rights

Data subjects have rights pertaining to their personal data, including the right to access, correct, delete, or transfer their data, as well as the right to object to its processing or restrict its use. At Pharmica.co.uk, we provide mechanisms for users to exercise these rights easily.

Data Security and Breach Notification

We implement technical and organisational measures to ensure a high level of security for personal data against unauthorized or unlawful processing, accidental loss, destruction, or damage. In the unlikely event of a data breach, we have protocols in place to promptly notify competent authorities and affected individuals.

Contact Information

For any inquiries or concerns regarding our use of your personal data, you may contact us at [email protected]. The owner of the website is Caspian Braxton, located at:

State Library Victoria
328 Swanston St, Melbourne VIC 3000, Australia

Share It on

Write a comment

about author

Matt Hekman

Matt Hekman

Hi, I'm Caspian Braxton, a pharmaceutical expert with a passion for researching and writing about medications and various diseases. My articles aim to educate readers on the latest advancements in drug development and treatment options. I believe in empowering people with knowledge, so they can make informed decisions about their health. With a deep understanding of the pharmaceutical industry, I am dedicated to providing accurate and reliable information to my readers.

Categories

Tags

our related post

related Blogs

Breakthrough Therapies for Rapidly Dividing Cancer Cells: Next-Gen Chemotherapy and Targeted Agents
25 Apr

Breakthrough Therapies for Rapidly Dividing Cancer Cells: Next-Gen Chemotherapy and Targeted Agents

Cancer treatments are getting smarter. This article digs into breakthrough therapies that zero in on rapidly dividing tumor cells, moving beyond old-school chemotherapy. From antibody-drug conjugates to the latest cell-cycle inhibitors and clever tricks to outwit tumor growth, we break down the science in plain language. Find out what's new, what's promising, and practical information if you're facing fast-growing cancer. Experts, patients, and anyone curious about where treatment is going will find useful insights here.

Read More
Why Patients Are Choosing RXConnected Alternatives in 2025: Pricing, Service, and Changing Regulations
22 May

Why Patients Are Choosing RXConnected Alternatives in 2025: Pricing, Service, and Changing Regulations

Patient loyalty to RXConnected.com is taking a hit in 2025, with shifting prices, evolving service quality, and stricter regulation sending folks searching for better deals and experiences. This article dives deep into why more people are ditching their former go-to pharmacy site and what they’re finding elsewhere. Get straight facts on price hikes, real customer headaches, and insider tips for making smarter pharmacy choices. Discover the latest alternatives and regulatory updates reshaping how Aussies buy their meds. The landscape is changing fast—find out how to stay ahead.

Read More

Cilostazol: A Drug with Multiple Therapeutic Applications

As a blogger, I recently came across an interesting drug named Cilostazol that has multiple therapeutic applications. Primarily, it is used to treat intermittent claudication, a condition caused by poor blood flow in the legs. Additionally, this drug has shown potential in the areas of platelet aggregation inhibition, stroke prevention, and even heart failure treatment. Its vasodilatory and anti-inflammatory properties make it a versatile medication with promising benefits. I can't wait to see how Cilostazol continues to evolve in the medical field and improve the lives of many patients.

Read More